NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
69468-151-04 | 69468-151 | HUMAN PRESCRIPTION DRUG | VISTOGARD | uridine triacetate | GRANULE | ORAL | 20160301 | N/A | NDA | NDA208159 | Wellstat Therapeutics Corporation | URIDINE TRIACETATE | 951 mg/g | 4 PACKET in 1 CARTON (69468-151-04) / 10 g in 1 PACKET (69468-151-10) |
69468-151-10 | 69468-151 | HUMAN PRESCRIPTION DRUG | VISTOGARD | uridine triacetate | GRANULE | ORAL | 20160301 | N/A | NDA | NDA208159 | Wellstat Therapeutics Corporation | URIDINE TRIACETATE | 951 mg/g | 10 g in 1 PACKET (69468-151-10) |
69468-151-20 | 69468-151 | HUMAN PRESCRIPTION DRUG | VISTOGARD | uridine triacetate | GRANULE | ORAL | 20160301 | N/A | NDA | NDA208159 | Wellstat Therapeutics Corporation | URIDINE TRIACETATE | 951 mg/g | 20 PACKET in 1 CARTON (69468-151-20) / 10 g in 1 PACKET (69468-151-10) |